Verus Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-320	Closed	-$228K	–	397
2024 Q4	$228K	Sell	320 -20	-6%	-$16.8K	0.02%	325
2024 Q3	$357K	Buy	340 +12	+4%	+$13.4K	0.04%	238
2024 Q2	$345K	Buy	328 +2	+0.6%	+$1.94K	0.04%	242
2024 Q1	$314K	Buy	326 +67	+26%	+$63.7K	0.03%	251
2023 Q4	$227K	Sell	259 -26	-9%	-$21.4K	0.03%	283
2023 Q3	$235K	Sell	285 -5	-2%	-$3.93K	0.03%	254
2023 Q2	$208K	Sell	290 -30	-9%	-$23.1K	0.03%	274
2023 Q1	$263K	Buy	+320	New	+$241K	0.04%	232
2022 Q4	–	Sell	-375	Closed	-$258K	–	287
2022 Q3	$258K	Sell	375 -50	-12%	-$31.5K	0.05%	221
2022 Q2	$252K	Sell	425 -135	-24%	-$87.8K	0.05%	239
2022 Q1	$364K	Buy	+560	New	+$354K	0.06%	226
2020 Q1	$38K	Sell	78 -162	-68%	-$66.8K	0.01%	584
2019 Q4	$90K	Buy	+240	New	+$80.7K	0.03%	409